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Introduction
O ver recent years, photosensitizers have been of increasing scientific interest in biomedical research due to their versatility and usability in many different fields and applications. These include wastewater treatment, fine chemical synthesis, and photodynamic applications such as blood sterilization and sunlight-activated herbicides and insecticides. 1 Rose Bengal (RB) is one of the most versatile of all the photosensitizers. Its low price combined with its wide availability and its photosensitive and sono-sensitive properties make RB a good candidate for use in biomedical research, as demonstrated by the increasing number of items in which Rose Bengal is used as a keyword in PubMed each year (Fig. 1) .
RB (4,5,6,7-tetrachloro-20,40 ,50,70-tetraiodofluorescein disodium), also known as Chemical Index Acid Red 94, is an anionic water-soluble xanthene dye and a halogen derivative of fluorescein that consists of three linearly arranged aromatic rings and an oxygen atom at the center (Fig. 2) . RB is a type II photosensitizer, meaning that once activated, it can transfer its energy directly to oxygen, resulting in the formation of singlet oxygen known as reactive oxygen species (ROS). This mechanism differs from type I reactions where the activated photosensitizer reacts with biomolecules or cell membranes, transferring hydrogen atoms to form free radicals, resulting in lower killing effectiveness. 2, 3 As a type II photosensitizer, RB converts triplet oxygen molecules into singlet oxygen on irradiation with green light (532 nm) via a photo-catalytic process. [4] [5] [6] [7] RB is FDA approved as a vital stain to assess the ocular surface, especially in the evaluation of dry eye treatments. 4 Moreover, as a dye, RB has been used for decades as a liver function assay in its radioactive I 131 form. 8 However, RB can also be combined with light or ultrasound for other applications in the medical field. Although some review papers on biomedical applications report the use of photo-and sono-activated RB, an overview of the complete spectrum of applications and main outcomes is missing. Considering the increasing use of RB in the biomedical field, there is a need for a comprehensive review of the extensive range of applications of photo-and sono-activated RB. This simplifies comparisons and analyses of procedures and results, raising awareness of all the ways in which photo-and sonoactivated RB can be applied.
In this review article, we aim at meeting this need, first by describing and discussing the biomedical applications of photo-activated RB, summarized into four main categories:
Photochemical tissue bonding (PTB) Photodynamic therapy (PDT) Photothrombotic animal models Other applications Second, we review applications of sono-activated RB, including:
Cancer treatment Antimicrobial therapy Lastly, the biomedical applications and future perspectives of photo-and sono-activated RB are discussed.
Photo-Activated RB

Photochemical tissue bonding
PTB is a tissue repair technique based on the use of a photosensitive dye, such as RB, combined with a light source to seal tissue surfaces together. The photosensitive dye absorbs photons of visible laser irradiation and, as a consequence, ROS are produced, which can react with electron donors and acceptors (e.g., amino acids in proteins).
This reaction promotes covalent bonding of structural proteins such as crosslinks in collagen type I molecules (Fig. 3) . As PTB is a nonthermal process, possible thermal injuries to tissues are avoided. This characteristic makes it preferable to laser welding, which provides tissue sealing using a laser beam with wavelengths in the mid-infrared region, which creates heat and, consequently, fuses and binds collagen. 9 Moreover, since it is driven by a photochemical mechanism, PTB is carried out at lower power than laser welding. [10] [11] [12] [13] Two main research groups have been working on the development of PTB using RB and green light, applying it to several tissues such as skin, blood vessels, nerves, tendons, and eyes for the purpose of repairing or binding biological tissues (Table 1) .
Skin. Skin is one of the first tissues used for application of PTB, and it is still one of the most tested. In 2002, PTB using RB and green light was applied to ex vivo porcine skin grafts for dermis-to-dermis bonding. 10 PTB was shown to enhance immediate graft adherence that increases with RB concentration and with laser fluence intensification. The maximum temperature reached on the tissue surface was 40°C, and histological test results revealed the absence of tissue damage and the retention of cell viability. The translation from ex vivo to in vivo was performed by Kamegaya et al., 14 who demonstrated the efficacy and safety of PTB treatment by repairing surgical incision and excision skin wounds in vivo in pigs. Subsequently, more research was performed on pig, rabbit, and mouse skin with successful results, 15 which allowed for subsequent studies in humans. In 2012, Tsao et al. 16 presented the first human study of PTB using photo-activated RB for skin wound closure based on molecular collagen-collagen crosslinks. No adverse reactions were observed and the scars had a better appearance compared with traditional suturing. To optimize this 17 demonstrated in pigs that in lightly pigmented skin the duration of the PTB treatment could be shortened; whereas in moderately and highly pigmented skin, a better balance of irradiation and cooling time is needed to achieve the same bonding strength. In fact, absorption of green light by the melanin contained in dark skin decreases the power absorbed, thus decreasing bonding strength.
Digestive system. The use of photo-activated RB for PTB has been implemented in chitosan-based laseractivated adhesives for application in the digestive system. Sectioned calf intestine was successfully bonded in vitro by using a chitosan film containing RB with minimal thermal increase after photo-activation. 9 Ark et al. used the combination chitosan-RB to create tissue scaffolds for device attachment in the digestive tract. 18 They demonstrated the feasibility of creating a light-activated adhesive scaffold by soaking a commercially available product (VariotisÔ; Biometic Pty Ltd., Sydney, Australia) with RB-chitosan solution and then illuminating it. Scaffold porosity, mechanical properties, and adherence to porcine stomach tissue were evaluated and resulted in sufficient tissue integration.
Cell culture showed enhanced biocompatibility when compared with uncoated Variotis. The developed RBchitosan scaffold could potentially be used as woundhealing patches for stomach ulcers or as a device attachment system, for example, anti-reflux valves in the esophagus. However, before proceeding to in vivo trials, the heat produced during PTB has to be mitigated. 18 Blood vessels. PTB techniques using photo-activated RB are also used in the vascular field, mainly for anastomoses. In a study by O'Neill et al., 19 PTB with photo-activated RB was used to perform microvascular anastomoses on porcine arteries ex vivo and on rat arteries in vivo. Results showed instantaneous bond, maintenance of patency, and superior leak point pressure when compared with sutured vessels both ex vivo and in vivo.
A limitation was the need for an intraluminal support to create the proper geometrical arrangement of the tissue and to avoid the bonding of the front and back of the vessel walls. This issue was resolved by using hollow polyvinyl alcohol stents for intraluminal support. 13 This was used on rats' arteries in vivo combined with PTB for microanastomoses, demonstrating immediate closure without leakage; however, long-term results were suboptimal due to high thrombosis rate caused by the nondegradable stent. The literature has not yet reported any clinical results of PTB technique on blood vessels.
Nervous system. Repair of peripheral nerves using the PTB technique with photo-activated RB instead of suturing would avoid multiple passages of the needle, foreign body reaction, and periodical positioning of sutures. 11 The use of photo-activated RB for nerve repair was evaluated on the epineural cuff in rats; peripheral nerves were shown to have bonded, and no significant differences were found in functional recovery and axonal regeneration compared with the gold standard suture repair. 11 Moreover, PTB-sealed amnion conduits were applied in rats to enhance regeneration across the nerve gap with outcomes comparable to standard autologous nerve grafting. 20 Tendons. Tendon repair techniques using PTB with photo-activated RB were explored by Chan et al. 21 They tested repair strength and reattachment of torn tendon fibers in an in vivo rat model, which proved to be comparable to untreated controls in terms of ultimate stress, therefore not providing sufficient mechanical strength. The same approach was further investigated in vivo in rabbits 22 combined with wrapping the Achilles tendon with an electrospun silk biomaterial. A significant effect in reducing postsurgical adhesions was demonstrated, but silk did not provide the mechanical strength of suturing early postsurgery. These findings demonstrate the poor suitability of PTB with photo-activated RB for tendon tissue.
Laryngeal surgery. RB and green light-based PTB was also applied in laryngeal surgery, for sealing vocal fold incisions after microflap resection 12 to avoid long-term scarring and to reduce postoperative voice rest. Ex vivo tests were performed on sheep tissue, followed by in vivo tests on 
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beagles. The technique result was effective, no long-term scarring of the vocal folds was detected, and no differences were found compared with controls. This study provides proof-of-concept that PTB with photo-activated RB can be used for laryngeal surgery, thus exploiting a quick and userfriendly process.
Cornea. The use of photo-activated RB to crosslink collagen has been widely applied on corneal tissue. Mulroy et al. 23 compared the effect of several photosensitizers activated by light for closing small keratome incisions in the cornea of enucleated rabbit eyes, a procedure named photochemical keratodesmos. The treatment of corneal damage with photo-activated RB was tested in terms of intraocular pressure required to cause leakage of fluid from the treated incision (IOPL). IOPL values were comparable to values reached after closure with sutures. Moreover, PTB allows for easy and effective repeatability of the treatment on previously treated incisions, which is skill intensive for sutured corneas. 23 Eri Verter et al. 24 evaluated PTB with photo-activated RB by using the amniotic membrane to seal penetrating corneal wounds. The amniotic membrane was stained with RB, applied to full-thickness incisional wounds on rabbit corneas, and irradiated with green laser both ex vivo and in vivo. Results showed immediate and strong bonding between amniotic membrane and corneal tissue, increasing IOPL with increasing fluence, compared with attachment using fibrin glue.
Cherfan et al. 25 tested photo-activated RB on corneas to treat keratoconus, a pathology consisting of thinning and weakening of the central corneal stroma and leading to sight impairment. Besides traditional therapies such as scleral contact lenses or intracorneal ring segments until keratoplasty, slower pathology progression was demonstrated after collagen crosslinking induced by riboflavin activated by ultraviolet (UV) irradiation. 26 However, the cytotoxic effect on keratocytes and the long UV irradiation time (30 min) led to exploring RB and green light to induce collagen crosslinking.
Increased corneal stiffness was shown in in ex vivo studies in RB and green light-treated rabbit eyes comparable to riboflavin-UV-treated samples, whereas the stiffening procedure was quicker and not toxic to the keratocytes. Similar results were found in porcine eyes ex vivo 27 when the biomechanical rigidity of the tissue and its resistance to collagenase digestion were tested. The safety of the treatment was demonstrated through histological analyses showing no thermal damage to retina and iris cells of rabbits after PTB in vivo.
28
Over recent years, more studies on the comparison between collagen crosslinking induced by photo-activated riboflavin and RB on ex vivo and in vivo efficacy, 29 corneal healing response, 30 and collagenase degradation 31 have been performed, showing that treatment with photo-activated RB is more effective than with riboflavin. Based on these results, photo-activated RB to crosslink corneal tissue is considered an attractive therapeutic approach for keratoconus and other disorders and its clinical application in humans should be explored in the near future.
In summary, photo-activated RB has been demonstrated to successfully bind several tissues by crosslinking collagen fibers. In fact, these positive outcomes are bringing PTB with photo-activated RB closer to clinical human application. For instance, the use of photo-activated RB to close skin wounds in daily clinical practice is under study at the Wellman Center for Photomedicine at Massachusetts General Hospital, which has licensed the PTB technology to a company specifically organized to introduce PTB into mainstream medical practice. 32 However, PTB using photo-activated RB has been shown to be unsuitable for some tissues, such as tendons, where the binding technique, in terms of crosslinking and stiffening, was found to be inefficient. RB has been shown to be versatile, not only because it was possible to apply it to different biological tissues but also for its potential to be combined with several materials, such as amniotic membrane in corneal treatments and chitosan in digestive tract surgery.
Photodynamic therapy
PDT is a treatment based on the activation of photosensitizers through light, ranging from UV to near-infrared wavelengths, in the presence of molecular oxygen, to induce cell death in specific applications such as cancer treatments or antimicrobial therapy. 2, 33 Depending on the photosensitizer, the type of substrate, and the oxygen concentration used, two different reactions can occur. Type I reactions are characterized by the interaction between the excited photosensitizer and the cell membrane or biomolecule. From these reactions, due to the moving of hydrogen atoms, free radicals are formed that, together with oxygen, produce oxygenated species.
In type II reactions, the energy is transferred directly from the excited photosensitizer to oxygen, resulting in the formation of ROS.
2 Both these ROS formation inducing reactions cause cell inactivation and death because of their interaction with intracellular components. 33 The action of photo-activated RB is mostly mediated via the type II pathway, leading to RB being an effective agent for PDT in antimicrobial therapy and cancer treatment.
Antimicrobial therapy. The antimicrobial effect of photoactivated RB on several microbes, fungi, and bacteria has been evaluated. The effect of xanthene photosensitizers was compared on biofilm and planktonic cells of Candida albicans, an opportunistic yeast that causes oral candidosis. 6, 34 There was a reduction of cells and biofilm that was proportional to the concentration of photosensitizers, with higher eosin efficacy compared with RB. Moreover, in similar applications in the dental field, RB resulted in effective inhibition of Streptococcus sanguinis and Streptococcus mutans.
35-37 Demidova and Hamblin 38 made a comparison between RB and the antimicrobial photosensitizers Toluidine blue O and poly-l-lysine chlorine(e6) conjugate, to assess the in vitro effect of PDT on Escherichia coli (gram-negative bacteria), Staphylococcus aureus (gram-positive bacteria), and C. albicans (yeast) for infection treatment.
In vitro results showed that photo-activated RB is more effective in killing S. aureus and E. coli than Toluidine blue O, also at low concentrations probably by entering the cell through a diffusion-controlled process, and it is less effective on C. albicans. The poly-l-lysine chlorine(e6) conjugate resulted in the most phototoxic compound on all bacteria.
The hypothesis for this effect is that both density and mass of cells compete for extracellularly generated ROS and for available dye binding. Wen et al. 39 demonstrated
improved inactivation of gram-negative bacteria, such as E. coli, by adding potassium iodide salt to photo-activated RB and comparing it with bacteria treated only with photoactivated RB, whereas inactivation of gram-positive bacteria such as methicillin-resistant S. aureus and Staphylococcus epidermidis was shown after treatment with RB-decorated silica nanoparticles. 40 Arboleda et al. 33 tested photo-activated RB on three types of fungi (Fusarium solani, Aspergillus fumigatus, C. albicans) and reported higher growth inhibition of all three types, especially C. albicans, compared with controls. The effectiveness of photo-activated RB against Fusarium keratoplasticum fungi in keratitis both in vitro and in vivo was also demonstrated by dropping RB solution into the patient's eye and irradiating it in the operating room, 41 and against Trichophyton rubrum.
2,42
As discussed by Spagnul et al., 3 RB for antimicrobial PDT can be incorporated into natural polymers, such as in chitosan nanoparticles or on to cellulose acetate surfaces. Manoil et al. 43 discussed the use of RB-Acetate against Enterococcus faecalis, resulting in reduced bacterial viability, whereas Decraene et al. 44 demonstrated reduced environmental contamination on clinical surfaces by using cellulose RB-Acetate coatings. RB can also be linked to synthetic polymers, such as silica, polystyrene, and polyethylene supports. The immobilization of photosensitizers on solid supports aims at allowing both efficient elimination of microorganisms and complete photosensitizer removal from the treated medium. 3 Other advantages of this technique are the possibility of recycling the photosensitizer used in the disinfection process and the photo-bleaching of the photosensitizers, which prevents their accumulation in the environment. 3 Cancer treatment. Several photosensitizers have been used for PDT for treating cancer due to their ability to induce ROS formation, which can cause cell death. 45 The efficacy of the substance depends on its physical and chemical characteristics, such as chemical purity, charge, solubility, distinct localization in cancer cells, residence, and accumulation time from drug administration. 45 RB is an anionic substance with low solubility in lipids which negatively affects its capability to cross biological membranes. For this reason, RB alone does not penetrate the tumor tissue easily. To improve RB uptake by cancer cells, RB was loaded into multivesicular and in light-triggered liposomes containing gold nanoparticles, and it was tested in vitro. 46, 47 Results showed good intracellular RB uptake and a consequent increase in cell death rate in the first case, and good cell-killing efficacy of RB combined with gold in the second case. Gold has also been used in the form of nanorods and combined with photo-activated RB to generate ROS for killing oral cancer cells through the integrated effect of PDT and photo-thermal therapy offers advantages such as high effectiveness and specificity to oral cells both in vitro and in vivo in a hamster tumor model. 48 Another way to improve RB cell uptake and treatment effectiveness is to link it to nanoparticles such as silicacoated upconverting nanoparticles. 49 These are used to create PDT nanoplatforms, 49 to join the PDT effect of RB with the degradation of the polymer shell for controlled drug release of chemotherapeutic drugs 50 and/or combined with antibodies for specific targeting of cancer cells. 51 Gianotti et al. 52 and Uppal et al. 53 developed organically modified silica nanoparticles with RB and showed phototoxicity on skin, 52 oral, and breast 53 cancer cells in vitro. Nanoparticles loaded with RB and made of different materials, such as ZnO 45 and PVP+Janus, 54 were studied, demonstrating greater ROS generation and toxicity in vitro and selectiveness for cancer cells, respectively.
Magnetic nanoclusters 55 and dendrimers 56 encapsulating RB have been tested, showing phototoxicity on breast, ovarian, and prostate cancer 55 and lymphoma cells. 56 Panzarini et al. 57 explored a new concept, termed Immunogenic Cell Death, where photo-activated RB appears promising in triggering apoptosis and autophagy of HeLa cells in vitro by designing the first cancer PDT protocol that induces relocalization of immunogenic molecules.
Photo-activated RB for use in PDT has demonstrated high effectiveness in two paramount applications: antimicrobial therapy and cancer treatment. In antimicrobial therapy, RB was shown to be suitable for killing both gram-positive and gram-negative bacteria and yeasts, thus proving to be an interesting candidate for antimicrobial application directly into the body for treatment of infection, and even for reduction of clinical environmental contamination. Inclusion of RB in liposomes or (nano)particles for localized therapy in cancer treatment proved to be effective in exploiting RBs versatility, which is illustrated by the possibility of combining it with other materials already demonstrated in PTB application.
Its promising future has also been demonstrated through its proven selectiveness of killing cancer cells over healthy cells in a broad range of cancer cells types, from skin to breast, prostate, and lymphoma. Despite its encouraging preliminary outcomes, the use of photo-activated RB for PDT, in cancer treatment in particular, is still limited to in vitro and in vivo animal studies due to its unclear mechanism of action.
Photothrombotic animal models
Blood vessel homeostasis has been shown to be controlled by the status of vascular endothelium. 58 Endothelial damage causes modifications of vasomotor activity and inflammatory response, which leads to repair or regeneration of damaged endothelial cells. 58 This process has an influence on the pathogenesis of cardiovascular diseases such as stroke, hypertension, and atherosclerosis. 58 However, the exact role of endothelial damage in triggering these pathologies is unclear.
Experimental models, in which the endothelium was injured, have been used to investigate regenerated endothelial function, but they are mainly based on mechanical approaches (e.g., catheterization, wire injuries). 59 Since the mechanical stress caused could provoke not only endothelial damage but also alterations in the extracellular matrix, a nonmechanical endothelial damage model is needed. 58 Application of photo-activated RB has been shown to be a nonmechanical and noninvasive methodology to initiate photochemically induced endothelial injury. 58 Proteins and lipids in the endothelial cell membrane interact with ROS developed by photo-activated RB, thus initiating peroxidative reactions that cause endothelial injury. 58 This methodology has been used in vivo to induce intravascular thrombosis (as a disease model) and to create neointimal thickening in various animal species (Table 2) .
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The first application of this technique was in cerebral vessels in rats that were treated with intravenously administered RB and then irradiated. This resulted in focal thrombosis, meaning a complete vessel occlusion, leading to cerebral infarction. 60, 61 Although initiated by thrombosis, the main characteristics of stroke were consistently reproduced in this model, allowing for assessment of several treatment regimens. 61 Moreover, inducing infarction in predetermined areas may help in studying the behavioral, functional, and structural consequences of acute and chronic stroke. The same method was applied to occlude the microcirculation in the rat inner ear to create a model of hearing loss to test drugs. 62 Results demonstrated that photochemical occlusion led to ischemic damage of stria vascularis and hair cells in the inner ear.
Matsuno et al. 63 investigated the use of photo-activated RB on the large arteries of rats to induce thrombosis. They then assessed the effect of heparin and tissue-type plasminogen activator for antithrombosis and thrombolytic activity. The developed model showed high reproducibility in inducing a transluminal thrombus that resembles clinical thrombus. Heparin and tissue-type plasminogen activator were shown to prevent arterial occlusion and to reperfuse the occluded artery, respectively. The same model was used to investigate intimal thickening in guinea-pig arteries, showing that occlusion leads to intimal thickening after thrombolysis, due to migration and proliferation of smooth muscle cells. 64 This method was adapted for application to mice for the evaluation of antiproliferative drugs. 65 In another application, endothelial injury was induced by photo-activated RB in hypercholesterolemic hamsters to study vascular remodeling and plaque development and rupture, showing that hypercholesterolemia influences the induction of plaque rupture via apoptosis of smooth muscle cells. 66 The photothrombotic animal model was mainly applied to small animals such as mice, 65 rats, 60, 62, 63 guineapigs, 64 and hamsters 66 first, and then to larger animals, such as monkeys. [67] [68] [69] In the large animal studies, cerebral microcirculation was impaired by using photo-activated RB to evaluate the efficacy and time windows of new drugs and treatments for acute ischemic stroke. 67 It was also used to evaluate limbs and the behavioral recovery process, 69 to analyze functions and drugs (e.g., edavarone) 68 and the effects of rehabilitation on infarcted brains. Results have demonstrated that this model provides an effective test platform with outcomes similar to clinical human results. Other analyses of endothelial function after denudation by photo-activated RB to study the pathogenesis of atherosclerosis were performed on rat femoral arteries. 58 Vasoconstrictive substances showed an increased response to acetylcholine compared with vasodilators in remodeled arteries after endothelial injury. Photo-activated RB was used on rat carotid arteries to damage endothelium in vivo, thus developing an intimal thickening model on which to test therapeutic agents (Natto extract and Ferulic acid). This demonstrated an antioxidant effect that counteracted endothelial proliferation and hyperplasia. 70, 71 Photo-activated RB was also used to create a successful and reproducible rat model of spinal cord injury inducing infarction, loss of neurons, and reactive gliosis for testing neuroprotective drugs. 72 All previous photothrombosis models had mainly focused on the short-term effects of photo-activated RB to induce lesions in blood vessels. However, Minol et al. 73 aimed at creating a long-lasting exposure of arteries to ROS produced by RB photo-activation to induce focal atherosclerosis-like lesions in an in vivo rat model without systemic side effects. Outcomes showed that after 56 days, aortic tissue showed media thickening and reduced expression of alpha smooth muscle actin compared with untreated controls, demonstrating the focal induction of vascular disease.
Photo-activated RB has demonstrated an ability to induce thrombosis and neointimal thickening in several in vivo animal models. They provide reproducible platforms to evaluate drugs, protocols, and treatments, allowing for testing under pathological conditions, which are closer to the real settings. However, the effect of photo-activated RB has only been analyzed in complex and complete models (animals in vivo) and not in endothelial or smooth muscle cells in in vitro and ex vivo settings. This could provide useful information on the onset and progression of the studied pathologies.
Other applications
Tissue engineering. Over recent years, the tissue engineering field has been growing and new techniques to produce scaffolds, especially made of natural polymers, have been developed. 74 Gel scaffolds are considered really useful for applications such as defect filling, since they can be provided liquid and crosslink on site. 75 However, spontaneous gelation does not always provide sufficient mechanical strength to constructs. Therefore, a method to obtain gelation in situ to enhance mechanical strength could be used to incorporate RB into the solution and photo-crosslink the scaffold. 75 This strategy has been tested on collagen gel scaffolds whose contraction and cell viability were evaluated after encapsulation of chondrocytes and fibroblasts, comparing photo-activated RB and riboflavin. 75 RB-crosslinked collagen gels resulted in lower chondrocyte viability, compared with riboflavin-crosslinked gels. Their mechanical properties were not yet analyzed. Several groups aimed at improving the technology of creating photo-crosslinked scaffolds, using RB specifically. Mazaki et al. 74 developed a novel furfurylamine-conjugated gelatine by using photoactivated RB as a crosslinker to increase the mechanical stiffness of the scaffold where bone marrow stromal cells were seeded for treatment of osteochondral injuries.
The newly developed material was tested in a rabbit defect model and it promoted cell viability and production of articular cartilage-like tissue as well as regenerated subchondral bone compared with untreated controls. Here, RB allowed for fast photo-induced crosslinking to form gels with a minimally invasive approach at specific sites in vivo, injecting the solution and increasing the stiffness of the material by just using visible light while maintaining good cell viability. Similarly, RB was used as a photo-crosslinker in collagen-based hydrogels, combined with a chemical crosslinking step, to improve stability, stiffness, and resistance to collagenase digestion without compromising the viability of encapsulated chondrocytes in vitro. 76 These results outline future applications of RB in the tissue engineering field.
Alzheimer's disease treatment. Another innovative and interesting application of photo-activated RB is the treatment of Alzheimer's disease, which is characterized by the abnormal aggregation of b-amyloid peptides in the brain, the suppression of which could represent a therapeutic solution. In in vitro cell studies, Lee et al. 77 showed that photo-activated RB action at an early stage interacted with b-amyloid self-assembly and inhibited conformational transition from monomer to sheet-rich structures due to vibration of excited RB and oxidation of b-amyloids. The high binding affinity of RB to b-amyloid also reduced the b-amyloid-induced cytotoxicity.
Another study 78 evaluated the use of RB for the treatment of tauopathies, such as Alzheimer's disease, and compared it with Methylene Blue (MB), which has similar photosensitive properties but a suboptimal safety profile in terms of toxicity. RB reduced tau accumulation and improved climbing activity in human tau-expressing Drosophila flies; survival was higher in the flies undergoing RB treatment compared with MB. The main open issue in bringing the treatment into human clinical practice is how to provide enough light to generate ROS in the brain. One possible solution, which is currently under evaluation, is the combination of using near-infrared light that penetrates into the cortical surface and other photosensitizers that act close to the infrared wavelength. 78 Vein passivation. In the cardiovascular field, photoactivated RB was used for photochemical tissue passivation, a technology that crosslinks surface proteins (e.g., adventitial collagen). 79 RB and green light were used in vivo in rats to increase collagen crosslinks of the venous adventitial layer to passivate and arterialize the tissue with the aim of enhancing the long-term patency of autologous veins used for coronary artery bypass grafting. 79 Results showed a positive decrease in vessel compliance, dilation of the graft, and intimal thickening. More research to study the acute biological effects of the treatment on vein grafts and an analysis on larger animal models are needed to proceed to the next steps.
RB Activated by Ultrasound
Cancer treatment
In addition to its use combined with green light, RB has also been applied in the medical field combined with ultrasound. Umemura et al. 80 found that some fluorescein derivatives such as RB can induce ultrasonic cavitation, defined as the generation and oscillation of gas bubbles, which may cause irreversible cell damage and modify membrane structure and functional properties of cells to induce lysis, necrosis, or apoptosis. 81 Therefore, they investigated sono-activated RB on isolated tumor cells. They have shown that hematoporphyrins and xanthene dyes, which are photosensitizers, can enhance the antitumoral effect of ultrasound, suggesting a new modality for treating tumors, namely sonodynamic therapy (SDT). The SDT penetrates to a greater depth than light, allowing for the treatment of cancer in deeper tissues. 80 Although RB was found to induce in vitro cell damage to sarcoma after sono-activation under specific conditions 80 and, specifically, that cancer cells (malignant melanoma, breast, and lung carcinoma) were more prone to being killed by ultrasound than normal cells after the treatment, 82 RB accumulates poorly in solid tumors. This is because it is excreted in the bile, leading to a suboptimal concentration in tumor tissue for killing cancer cells. To overcome this, new amphiphilic RB derivatives were synthesized and tested to enhance their selectiveness for cancer cells. When compared with RB alone, these new derivatives showed a higher concentration in colon carcinoma in mice. 83 Moreover, sonically activated RB derivatives were shown to induce increased in vitro cell damage to sarcoma cells when compared with sono-activated RB or ultrasound-treated cells without RB. 84 Nonaka et al. 81 applied SDT with RB and focused ultrasound to experimental intracranial glioma in rats, resulting in selective reduction of the tumor area without damaging the surrounding tissue. They also applied it to the bloodbrain barrier in rats, 85 showing increased permeability and enhanced opening of capillary endothelial cell tight junctions, allowing for better passage of drugs into malignant PHOTO-AND SONO-ACTIVATED ROSE BENGAL 389 tumor cells than ultrasound alone. McEwan et al. 86 demonstrated the possibility of injecting ultrasound-responsive microbubbles bearing an RB sensitizer to induce a statistically significant reduction in pancreatic tumor growth. In subsequent studies, 87, 88 modification of the microbubble technique has been implemented to enhance the efficacy of delivering oxygen to the tumor microenvironment, thus increasing the amount of ROS generated.
RB has also been included in nanoparticles in which graphene oxide/porous silica nanosheets capped with RBconjugated iron oxide nanoparticles were designed to be sonodynamic agents, to improve cytotoxicity in cancer cells. 89 Damage to both superficial and deep tumor regions was achieved in vivo in mice by using a combination of sono-activated RB, sono-hyperthermia, and magnetic guidance of the nanoparticles and subsequent focused sonication. 89 Despite the promising results, more data and insight on the mechanisms inducing cancer cells killing are needed to better study dosimetry and synergistic effects.
Antimicrobial therapy
A further application of sono-activated RB was reported by Nakonechny et al. 90 They demonstrated eradication of gram-positive and gram-negative bacteria, such as E. coli and S. aureus, by applying SDT using activated sonosensitizers in vitro. Sono-activated RB was shown to be a potentially effective antimicrobial method in vivo, and as cold sterilization for medical instrumentation.
Comparison of photo-and sono-activated RB Several studies have compared the various applications of photo-activation and sono-activation of RB. Hiraoka et al. 91 evaluated free radical formation and human lymphoma cell killing in cancer treatment due to the sonodynamic and photodynamic effects of several photosensitizers in vitro, including RB. Results show that cell survival rate was about 60% after RB incubation (at the same concentration) in both photo-and sono-activated groups. In a study by McCaughan et al., 92 RB and MB were photo-and/or sono-activated and tested on hamster ovarian cells in vitro for cytotoxicity for application in cancer treatment. Photo-and sono-activated RB were demonstrated to be more cytotoxic than MB. Cancer cell reduction indicated enhanced toxicity (75%) when both photo-and sono-activation were used, whereas there was no significant difference of cell reduction between photo-and sono-activated RB (45% and 58%, respectively).
The cytotoxic ability of sono-activated and photo-activated RB was also tested on a B16-melanoma cell line and in an ectopic tumor model in vitro and finally in vivo in mice. 93 Results showed that sono-activated RB was significantly more cytotoxic than photo-activated RB in the melanoma model, both in vitro and in vivo, probably due to the dark pigmentation of melanoma cells that filtered the excitation light, thus avoiding the sensitizer activation. Comparison between photo-and sono-activated RB (Table 3) gives rise to speculation about a number potential applications for RB.
Conclusions
This review highlights the potential of RB combined with green light and ultrasound for biomedical applications. Photoactivation of RB has been shown to be versatile and applicable to a wide range of tissues and materials in many fields, giving an important role to RB in the biomedical world. The flexibility of the RB-green light treatment offers the possibility of improving existing methods (e.g., corneal crosslinking for eye pathologies) as well as exploring novel solutions for new medical needs (e.g., Alzheimer's disease treatment).
The potential of RB is not only limited to activation with the green light, but its activation by ultrasound could be an interesting alternative. These two ways of activating RB should not be considered as competitors; on the contrary, each method should be analyzed in relation to the intended application. For instance, RB photo-activation can be used for external application on the body, such as wound sealing or corneal crosslinking, whereas the use of sono-activated RB could be further explored where deeper tissue penetration is needed, for example in cancer treatment.
Moreover, a comparison between photo-and sonoactivated RB for the same application could be carried out to explore whether similar effects are shown. To reduce risks, the lasers that are necessary for the green light activation In vitro n = 3 Similar decrease of cell survival comparing photo-activated with sono-activated RB (same concentration) McCaughan et al. 92 In vitro n = 4 Similar cytotoxicity comparing photo-activated with sono-activated RB (same concentration); enhanced toxicity when both photo-and sono-activation are used McEwan et al. 93 In vitro and in vivo n = 3 Improved reduction in viability of melanoma cells comparing sono-activated with photo-activated RB
Advantages Disadvantages
Photo-activated RB Known mechanism 92 Superficial penetration into tissues 92 Higher number of RB PDT studies Activation affected by possible filtering of excitation light 93 Sono-activated RB Tissue attenuation that allows to deliver energy to deep tissues 92 Unclear mechanism 92 Clinically approved as safe 93 Lower number of RB SDT studies PDT, photodynamic therapy; RB, Rose Bengal; SDT, sonodynamic therapy.
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and require special safety measures could be replaced by ultrasound machines that are readily available in hospitals.
Comparisons of various photo-and sono-activated RB treatments have been made in the areas of cancer treatment and antimicrobial therapy, but further studies could focus on collagen crosslinking after sono-activated RB treatment or on inducing the same thrombotic lesions in animals using ultrasound instead of light to activate RB. The use of activated RB appears very promising for applications such as PTB on skin, as the long-term outcomes have been shown to be positive. The procedure results in easy and low-risk; therefore, we expect to see this technique in clinical practice in the near future. However, other applications, such as cancer treatment, are still far from being implemented into the clinic, probably due to the lack of understanding of the precise mechanism behind photo-or sono-activated RB that could lead to the underestimation of possible side or long-term effects and for the complexity of the pathology and its therapies.
As discussed, activated RB has several biomedical applications in treating a broad range of pathologies; nevertheless, another interesting implementation is its use to induce vascular thrombosis in in vivo animal models. In this case, the pathology is created and not cured, thus giving a different role to RB. This application opens the way to exploiting the properties of activated RB in the research world as a support tool rather than a treatment option.
In the cardiovascular field, the use of activated RB focuses mainly on in vivo application in animal models, such as induction of thrombosis and neointimal damage, blood vessel bonding, and vein passivation. Nowadays, for ethical reasons, an increasing number of research groups are using ex vivo models to reduce animal experimentation and to lower testing complexity. Therefore, an interesting development would be to apply the activated RB technique in these ex vivo models with the advantage of having reproducible and controllable models in which pathologies can be induced and therapies can be tested.
In conclusion, we believe that more research is needed to explore the mechanisms and safety and to exploit all the features and advantages of activated RB. We envision that due to the promising results already obtained in various fields and the interesting perspectives that RB offers, more studies will be focusing on the use of RB in biomedical applications in the future.
